Sensitive ASX Announcement

Leading CRO Appointed for Phase 2 Crohn's Trial

Published: 01/10/26, 09:38am (AEST)•3 pages
Miro Sciences
MSX:ASX•Healthcare

Recent MSX Announcements

Price Sensitive only